Home › Funds › RICE HALL JAMES & ASSOCIATES, LLC › MIRM

RICE HALL JAMES & ASSOCIATES, LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

RICE HALL JAMES & ASSOCIATES, LLC reported holding 110,673 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$13.0M, representing 0.63% of its reported portfolio and ranking #50 among its reported holdings. RICE HALL JAMES & ASSOCIATES, LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)110.67K sh
Reported value held$12.96M
Portfolio Weight0.63%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RICE HALL JAMES & ASSOCIATES, LLC's MIRM position evolved

RICE HALL JAMES & ASSOCIATES, LLC first disclosed a stake in MIRM in Q3 2023 at 53,379 shares (US$1.7M). The position peaked in Q1 2026 at 147,037 shares, worth US$13.6M. Across 12 filings, RICE HALL JAMES & ASSOCIATES, LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 110,673 shares valued at US$13.0M — a reduction of -36,364 shares quarter over quarter.. Notable position changes include a 402% increase in Q1 2024 (shares rose 36% over the following quarter), a 29% trim in Q3 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 53.38K $1.69M New
Q4 2023 42.84K $1.26M Reduce
Q1 2024 214.89K $5.40M Add
Q2 2024 229.73K $7.85M Add
Q3 2024 242.71K $9.47M Add
Q4 2024 239.00K $9.88M Reduce
Q1 2025 234.70K $10.57M Reduce
Q2 2025 231.99K $11.81M Reduce
Q3 2025 164.75K $12.08M Reduce
Q4 2025 164.45K $12.99M Hold
Q1 2026 147.04K $13.58M Reduce
Q2 2026 110.67K $12.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has RICE HALL JAMES & ASSOCIATES, LLC held MIRM?

RICE HALL JAMES & ASSOCIATES, LLC has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is RICE HALL JAMES & ASSOCIATES, LLC's current position in MIRM?

As of Q2 2026, RICE HALL JAMES & ASSOCIATES, LLC holds 110.67K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $12.96M, representing 0.63% of its reported portfolio and ranking #50.

Has RICE HALL JAMES & ASSOCIATES, LLC been buying or selling MIRM?

In the latest 13F filing (Q2 2026), RICE HALL JAMES & ASSOCIATES, LLC reduced its position in MIRM. The position peaked in Q1 2026 at 147.04K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.